J.P. Morgan Securities LLC and TripleTree, LLC acted as financial advisors to GoodRx. Kirkland & Ellis LLP and M&H, LLP served as legal counsel to GoodRx. Ropes & Gray LLP and Epstein Becker & Green, P.C. served as legal counsel to Silver Lake.
GoodRx, America’s leading source for prescription and healthcare savings, closed a strategic growth investment from Silver Lake, the global leader in technology investing. Financial terms of the transaction were not disclosed.
GoodRx provides current prices and discounts for prescriptions at pharmacies across America. The company’s website and mobile apps have helped Americans struggling with the high cost of healthcare to save over $6.5 billion since the company’s founding in 2011. More than 10 million Americans use GoodRx every month to lower the cost of their healthcare, and more than one-third of U.S. doctors provide information about GoodRx to their patients.
Silver Lake is the global leader in technology investing, with about $40 billion in combined assets under management and committed capital and a team of approximately 100 investment and value creation professionals located in Silicon Valley, New York, London, Hong Kong and Tokyo. Silver Lake’s portfolio of investments collectively generates more than $170 billion of revenue annually and employs more than 340,000 people globally.
The Ropes & Gray team was led by private equity partners Alfred Rose (Picture) and Eric Issadore, health care partners Timothy McCrystal and Eve Brunts, finance partner Byung Choi and tax partner Adam Greenwood.
Kirkland & Ellis advised GoodRx with a team including corporate partners Adam Phillips and Lilit Voskanyan; tax partner Keith Villmow; executive compensation partner Michael Krasnovsky; and debt finance partner Chris Kirkham.
Involved fees earner: Alfred Rose – Ropes & Gray; Eric Issadore – Ropes & Gray; Timothy McCrystal – Ropes & Gray; Eve Brunts – Ropes & Gray; Byung Choi – Ropes & Gray; Adam Greenwood – Ropes & Gray; Adam Phillips – Kirkland & Ellis; Lilit Voskanyan – Kirkland & Ellis; Keith Villmow – Kirkland & Ellis; Michael Krasnovsky – Kirkland & Ellis; Christopher Kirkham – Kirkland & Ellis;